High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum B-lactam drugs in intensive care units
- 31 January 2000
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 36 (1) , 53-56
- https://doi.org/10.1016/s0732-8893(99)00108-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Multiple Antibiotic–Resistant Klebsiella and Escherichia coli in Nursing HomesJAMA, 1999
- Antibiotic Susceptibility Among Aerobic Gram-negative Bacilli in Intensive Care Units in 5 European CountriesJAMA, 1999
- Multicenter Evaluation of the Antimicrobial Activity for Six Broad-Spectrum β-Lactams in Venezuela Using the Etest MethodDiagnostic Microbiology and Infectious Disease, 1998
- Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia using the etest methodDiagnostic Microbiology and Infectious Disease, 1997
- The intensive care unit: the hottest zoneCurrent Opinion in Infectious Diseases, 1997
- The Evolution of Resistance to CephalosporinsClinical Infectious Diseases, 1997
- Antimicrobial Resistance Rates Among Aerobic Gram-Negative Bacilli Recovered from Patients in Intensive Care Units: Evaluation of a National Postmarketing Surveillance ProgramClinical Infectious Diseases, 1996
- Antibiotic resistance and production of extended-spectrum β-Mactamases amongst Klebsiella spp. from intensive care units in EuropeJournal of Antimicrobial Chemotherapy, 1996
- Ceftazidime-Resistant Klebsiella pneumoniae Isolates Recovered at the Cleveland Department of Veterans Affairs Medical CenterClinical Infectious Diseases, 1996
- Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 1989